{"id":"W4387407582","doi":"10.1016/j.esmoop.2023.102006","title":"157P PCM4EU academy: An educational program for precision oncology","year":2023,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Chugai Pharmaceutical; BeiGene; Eisai Canada; Centre Léon Bérard; Daiichi Sankyo Europe; Servier; Eisai; Basilea Pharmaceutica; Genentech; Institut Gustave-Roussy; PharmaMar; European Society for Medical Oncology; Pfizer; Incyte; Boston Pharmaceuticals; Clovis Oncology; Les Laboratories Pierre Fabre; Loxo Oncology; Astex Pharmaceuticals; Bayer HealthCare; Exelixis; Amgen; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Agios Pharmaceuticals","keywords":"Reimbursement; Oncology; Medical education; Portfolio; Clinical trial; Internal medicine; Medicine; Psychology; Health care; Political science","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002767354,0.00008560744,0.0001053786,0.00002974229,0.0001007495,0.00007060287,0.0004335433,0.0001565867,0.00006781372],"category_scores_gemma":[0.0001732008,0.00008552263,0.00004502012,0.00008559853,0.00003396434,0.000005762663,0.0003176845,0.00005448744,0.00005779935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002699343,"about_ca_system_score_gemma":0.0003339832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008062401,"about_ca_topic_score_gemma":0.0002471956,"domain_scores_codex":[0.9992597,0.00002532282,0.0001409105,0.0003157251,0.00005660175,0.0002017307],"domain_scores_gemma":[0.9995347,0.00006383223,0.00005310598,0.0001995353,0.00005576985,0.00009310114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004482511,0.000580975,0.002450303,0.00002143146,0.00007741959,0.000001685217,0.0001613703,0.000255947,0.02169192,0.006173675,0.5221003,0.4460368],"study_design_scores_gemma":[0.0005937316,0.0008225039,0.01511624,0.000005224505,0.00001107563,0.000003625149,0.00004074463,0.0002073096,0.01046815,0.003502292,0.9690959,0.0001332218],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9677007,0.0002189712,0.0003858742,0.01155627,0.001134747,0.00345135,0.0002782915,0.00005051952,0.01522328],"genre_scores_gemma":[0.9495561,0.0008530873,0.02128056,0.003295754,0.002697509,0.003198178,0.005648886,0.00008980048,0.01338016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4469956,"threshold_uncertainty_score":0.3487512,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05007142131481863,"score_gpt":0.432178044634972,"score_spread":0.3821066233201534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}